MOUNTAIN VIEW, Calif., June 29, 2011 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM), a complete human genome sequencing company, today announced that it is introducing a new cancer grant program. Winning research applications will receive complete human genome sequencing of eight genomes — four tumor/normal pairs. Four winning entries will be chosen: two each from the United States and Europe.
